Fiser R T, Walker W M, Seibert J J, McCarthy R, Fiser D H
Department of Pediatric, University of Arkansas for Medical Science/Arkansas Children's Hospital, Little Rock 72202-3591, USA.
Pediatr Emerg Care. 1997 Jun;13(3):186-8. doi: 10.1097/00006565-199706000-00003.
Intraosseous infusion is a well accepted means of obtaining emergency intravascular access in children. Despite the low incidence of serious complications from intraosseous infusions, the potential exists for growth plate injury and subsequent growth disturbance following intraosseous infusion. We conducted a prospective, blinded observational study of 10 subjects to evaluate tibial length discrepancy radiographically one year or more following intraosseous infusion. We found no significant difference in mean tibial length between the legs that had intraosseous infusions and the opposite legs, which served as controls. We conclude that intraosseous infusion does not appear to produce subsequent leg length discrepancy one year after infusion.
骨髓腔内输注是一种在儿童中广泛接受的获取紧急血管通路的方法。尽管骨髓腔内输注引起严重并发症的发生率较低,但骨髓腔内输注后仍存在生长板损伤及随后生长障碍的可能性。我们对10名受试者进行了一项前瞻性、盲法观察研究,以在骨髓腔内输注一年或更长时间后通过X线片评估胫骨长度差异。我们发现接受骨髓腔内输注的一侧下肢与作为对照的对侧下肢之间的平均胫骨长度无显著差异。我们得出结论,骨髓腔内输注在输注一年后似乎不会导致后续的下肢长度差异。